Table of Content

1 Psoriasis Drugs Market Introduction and Overview
1.1 Psoriasis Drugs Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Psoriasis Drugs Revenue and Market Share by Manufacturer
2.2 Manufacturers Psoriasis Drugs Production Sites, Area Served, Product Types
2.3 Psoriasis Drugs Market Competitive Situation and Trends
2.3.1 Psoriasis Drugs Market Concentration Rate
2.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2024
2.3.3 Mergers & Acquisitions, Expansion
3 Players Profiles
3.1 AbbVie
3.1.1 AbbVie Company Profile
3.1.2 Psoriasis Drugs Product Overview
3.1.3 AbbVie Psoriasis Drugs Market Performance (2019-2024)
3.1.4 AbbVie Business Overview
3.2 Amgen
3.2.1 Amgen Company Profile
3.2.2 Psoriasis Drugs Product Overview
3.2.3 Amgen Psoriasis Drugs Market Performance (2019-2024)
3.2.4 Amgen Business Overview
3.3 Johnson & Johnson
3.3.1 Johnson & Johnson Company Profile
3.3.2 Psoriasis Drugs Product Overview
3.3.3 Johnson & Johnson Psoriasis Drugs Market Performance (2019-2024)
3.3.4 Johnson & Johnson Business Overview
3.4 Novartis
3.4.1 Novartis Company Profile
3.4.2 Psoriasis Drugs Product Overview
3.4.3 Novartis Psoriasis Drugs Market Performance (2019-2024)
3.4.4 Novartis Business Overview
3.5 Eli Lilly & Company
3.5.1 Eli Lilly & Company Company Profile
3.5.2 Psoriasis Drugs Product Overview
3.5.3 Eli Lilly & Company Psoriasis Drugs Market Performance (2019-2024)
3.5.4 Eli Lilly & Company Business Overview
3.6 AstraZeneca
3.6.1 AstraZeneca Company Profile
3.6.2 Psoriasis Drugs Product Overview
3.6.3 AstraZeneca Psoriasis Drugs Market Performance (2019-2024)
3.6.4 AstraZeneca Business Overview
3.7 Celgene Corporation
3.7.1 Celgene Corporation Company Profile
3.7.2 Psoriasis Drugs Product Overview
3.7.3 Celgene Corporation Psoriasis Drugs Market Performance (2019-2024)
3.7.4 Celgene Corporation Business Overview
3.8 UCB
3.8.1 UCB Company Profile
3.8.2 Psoriasis Drugs Product Overview
3.8.3 UCB Psoriasis Drugs Market Performance (2019-2024)
3.8.4 UCB Business Overview
3.9 Merck
3.9.1 Merck Company Profile
3.9.2 Psoriasis Drugs Product Overview
3.9.3 Merck Psoriasis Drugs Market Performance (2019-2024)
3.9.4 Merck Business Overview
4 Global Psoriasis Drugs Historical and Forecast Market Analysis by Type
4.1 Global Psoriasis Drugs Revenue and Market Share by Type
4.2 Global Psoriasis Drugs Revenue Market Forecast by Type (2024-2030)
5 Global Psoriasis Drugs Historical and Forecast Market Analysis by Application
5.1 Global Psoriasis Drugs Revenue Market Share by Application (2019-2024)
5.2 Psoriasis Drugs Revenue Market Forecast by Application (2024-2030)
6 Global Market Growth Trends Analysis
6.1 Global Psoriasis Drugs Market Size & Forecast (2019-2030)
6.2 Psoriasis Drugs Growth Trends Analysis by Regions
6.2.1 Psoriasis Drugs Market Size by Regions: 2019 VS 2024 VS 2030
6.2.2 Psoriasis Drugs Historic Revenue Market Size by Regions (2019-2024)
6.2.3 Psoriasis Drugs Forecasted Revenue Market Size by Regions (2024-2030)
6.2.4 North America Psoriasis Drugs Market Size & Forecast (2019-2030)
6.2.5 Europe Psoriasis Drugs Market Size & Forecast (2019-2030)
6.2.6 China Psoriasis Drugs Market Size & Forecast (2019-2030)
6.2.7 Japan Psoriasis Drugs Market Size & Forecast (2019-2030)
6.2.8 Korea Psoriasis Drugs Market Size & Forecast (2019-2030)
6.2.9 Southeast Asia Psoriasis Drugs Market Size & Forecast (2019-2030)
6.2.10 India Psoriasis Drugs Market Size & Forecast (2019-2030)
6.2.11 South America Psoriasis Drugs Market Size & Forecast (2019-2030)
6.2.12 Middle East & Africa Psoriasis Drugs Market Size & Forecast (2019-2030)
7 North America
7.1 North America Psoriasis Drugs Revenue by Players
7.2 North America Psoriasis Drugs Revenue by Types
7.3 North America Psoriasis Drugs Revenue by Applications
7.4 North America Psoriasis Drugs Revenue, Gross and Gross Margin (2019-2024)
7.5 North America PEST Analysis
8 Europe
8.1 Europe Psoriasis Drugs Revenue by Players
8.2 Europe Psoriasis Drugs Revenue by Types
8.3 Europe Psoriasis Drugs Revenue by Applications
8.4 Europe Psoriasis Drugs Revenue, Gross and Gross Margin (2019-2024)
8.5 Europe PEST Analysis
9 China
9.1 China Psoriasis Drugs Revenue by Players
9.2 China Psoriasis Drugs Revenue by Types
9.3 China Psoriasis Drugs Revenue by Applications
9.4 China Psoriasis Drugs Revenue, Gross and Gross Margin (2019-2024)
9.5 China PEST Analysis
10 Japan
10.1 Japan Psoriasis Drugs Revenue by Players
10.2 Japan Psoriasis Drugs Revenue by Types
10.3 Japan Psoriasis Drugs Revenue by Applications
10.4 Japan Psoriasis Drugs Revenue, Gross and Gross Margin (2019-2024)
10.5 Japan PEST Analysis
11 Korea
11.1 Korea Psoriasis Drugs Revenue by Players
11.2 Korea Psoriasis Drugs Revenue by Types
11.3 Korea Psoriasis Drugs Revenue by Applications
11.4 Korea Psoriasis Drugs Revenue, Gross and Gross Margin (2019-2024)
11.5 Korea PEST Analysis
12 Southeast Asia
12.1 Southeast Asia Psoriasis Drugs Revenue by Players
12.2 Southeast Asia Psoriasis Drugs Revenue by Types
12.3 Southeast Asia Psoriasis Drugs Revenue by Applications
12.4 Southeast Asia Psoriasis Drugs Revenue, Gross and Gross Margin (2019-2024)
12.5 Southeast Asia PEST Analysis
13 India
13.1 India Psoriasis Drugs Revenue by Players
13.2 India Psoriasis Drugs Revenue by Types
13.3 India Psoriasis Drugs Revenue by Applications
13.4 India Psoriasis Drugs Revenue, Gross and Gross Margin (2019-2024)
13.5 India PEST Analysis
14 South America
14.1 South America Psoriasis Drugs Revenue by Players
14.2 South America Psoriasis Drugs Revenue by Types
14.3 South America Psoriasis Drugs Revenue by Applications
14.4 South America Psoriasis Drugs Revenue, Gross and Gross Margin (2019-2024)
14.5 South America PEST Analysis
15 Middle East & Africa
15.1 Middle East & Africa Psoriasis Drugs Revenue by Players
15.2 Middle East & Africa Psoriasis Drugs Revenue by Types
15.3 Middle East & Africa Psoriasis Drugs Revenue by Applications
15.4 Middle East & Africa Psoriasis Drugs Revenue, Gross and Gross Margin (2019-2024)
15.5 Middle East & Africa PEST Analysis
16 Psoriasis Drugs Business Cost Analysis
16.1 Proportion of Business Cost Structure
16.1.1 Labor Cost
16.1.2 Operating Expenses
16.2 Psoriasis Drugs Industrial Chain Analysis
17 Psoriasis Drugs Industry Dynamic Analysis
17.1 Psoriasis Drugs Market Trends Analysis
17.2 Psoriasis Drugs Market Drivers Analysis
17.3 Psoriasis Drugs Market Challenges Analysis
17.4 Psoriasis Drugs Market Restraints Analysis
18 Research Findings and Conclusion